ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 57 filers reported holding ALPINE IMMUNE SCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,202,064 | +13.4% | 628,925 | +1.8% | 0.00% | 0.0% |
| Q2 2023 | $6,352,772 | +47.9% | 617,974 | +11.1% | 0.00% | 0.0% |
| Q1 2023 | $4,293,918 | +120177.8% | 556,207 | +14.5% | 0.00% | 0.0% |
| Q4 2022 | $3,570 | -99.8% | 485,750 | +93.1% | 0.00% | – |
| Q3 2022 | $1,810,000 | -14.2% | 251,504 | +1.4% | 0.00% | – |
| Q2 2022 | $2,110,000 | +9.4% | 247,992 | +15.3% | 0.00% | – |
| Q1 2022 | $1,929,000 | -29.2% | 215,156 | +9.4% | 0.00% | – |
| Q4 2021 | $2,723,000 | +31.5% | 196,666 | +1.4% | 0.00% | – |
| Q3 2021 | $2,070,000 | +20.1% | 194,021 | +1.3% | 0.00% | – |
| Q2 2021 | $1,723,000 | +76.5% | 191,538 | +107.9% | 0.00% | – |
| Q1 2021 | $976,000 | +0.3% | 92,142 | +19.3% | 0.00% | – |
| Q4 2020 | $973,000 | +135.6% | 77,227 | +64.0% | 0.00% | – |
| Q3 2020 | $413,000 | +9.8% | 47,082 | +21.4% | 0.00% | – |
| Q2 2020 | $376,000 | +251.4% | 38,774 | +3.6% | 0.00% | – |
| Q1 2020 | $107,000 | -62.6% | 37,436 | -50.0% | 0.00% | – |
| Q4 2019 | $286,000 | +95.9% | 74,872 | +100.0% | 0.00% | – |
| Q3 2019 | $146,000 | -7.0% | 37,436 | 0.0% | 0.00% | – |
| Q2 2019 | $157,000 | -38.7% | 37,436 | 0.0% | 0.00% | – |
| Q1 2019 | $256,000 | -6.6% | 37,436 | -49.9% | 0.00% | – |
| Q4 2018 | $274,000 | +16.1% | 74,680 | +100.0% | 0.00% | – |
| Q3 2018 | $236,000 | -0.8% | 37,340 | +18.6% | 0.00% | – |
| Q2 2018 | $238,000 | -5.2% | 31,490 | 0.0% | 0.00% | – |
| Q1 2018 | $251,000 | -28.7% | 31,490 | 0.0% | 0.00% | – |
| Q4 2017 | $352,000 | -3.3% | 31,490 | 0.0% | 0.00% | – |
| Q3 2017 | $364,000 | – | 31,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 6,708,288 | $76,809,898 | 25.63% |
| Lynx1 Capital Management LP | 2,404,614 | $27,532,830 | 18.21% |
| GREAT POINT PARTNERS LLC | 3,078,633 | $35,250,348 | 6.42% |
| Ghost Tree Capital, LLC | 664,132 | $7,604,311 | 2.50% |
| Frazier Life Sciences Management, L.P. | 2,985,757 | $34,186,918 | 2.27% |
| Paradigm Biocapital Advisors LP | 2,421,743 | $27,728,957 | 1.88% |
| COMMODORE CAPITAL LP | 1,325,000 | $15,171,250 | 1.77% |
| Nan Fung Group Holdings Ltd | 182,280 | $2,087,106 | 1.69% |
| Omega Fund Management, LLC | 153,700 | $1,759,865 | 1.62% |
| Octagon Capital Advisors LP | 750,000 | $8,587,500 | 1.32% |